BioNTech SE is 13.0x more valuable than aTYR PHARMA INC by market capitalization ($21.79 B vs $1.67 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LIFE | BNTX |
|---|---|---|
| Market cap | $1.67 B | $21.79 B |
| US-listed rank | #2240 | #587 |
| Revenue (latest FY) | $190.00K | - |
| Net income (latest FY) | -$74.12M | - |
| Net margin | -39009.5% | - |
| SEC filings | 720 | 548 |
BioNTech SE is 13.0x more valuable than aTYR PHARMA INC by market capitalization ($21.79 B vs $1.67 B).
Full pages: aTYR PHARMA INC and BioNTech SE, or browse the full rankings.